|
Real-time Estimate
Cboe BZX
16:51:41 14/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.135 USD | +0.44% |
|
-4.54% | -51.24% |
| 08-13 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.44% | -4.54% | -7.64% | -60.96% | -51.24% | -39.57% | -11.94% | -93.88% | - | 65.81M | |
| -2.11% | -1.68% | -6.83% | +51.68% | +66.86% | +43.40% | +95.58% | +10.94% | - | 66.93B | |
| +0.82% | -0.90% | +18.00% | +13.19% | +20.20% | +35.05% | +75.55% | +211.72% | +5,587.13% | 61.97B | |
| -1.82% | +2.93% | +3.89% | +31.90% | -26.14% | -10.19% | +382.00% | +370.88% | +825.49% | 28.26B | |
| +4.55% | +1.36% | +8.86% | +58.93% | +56.30% | +26.52% | +17.28% | -58.11% | - | 24.59B | |
| +2.18% | +0.01% | +5.99% | +8.67% | +3.64% | +0.81% | -13.30% | -70.54% | - | 24.3B | |
| +0.86% | -1.54% | +4.00% | +32.25% | +4.00% | +18.49% | -22.21% | -24.17% | +95.19% | 19.41B | |
| -3.03% | -2.29% | -11.42% | +49.62% | +202.10% | +181.72% | +333.47% | +1,524.41% | +785.21% | 16.77B | |
| +3.44% | -1.88% | -7.55% | +14.79% | +22.69% | -5.46% | +547.21% | - | - | 14.18B | |
| +5.67% | +6.89% | +38.35% | +30.71% | +5.60% | -2.48% | +867.02% | +188.59% | +195.52% | 14B | |
| +0.70% | -2.25% | +10.02% | +6.37% | +28.62% | +44.51% | +153.14% | +180.05% | +333.32% | 13.91B | |
| +0.72% | -0.22% | +5.01% | +6.65% | -8.48% | +25.23% | +203.97% | +573.12% | +5,054.55% | 12.35B | |
| +0.04% | -3.31% | -5.02% | +6.66% | +23.95% | +187.02% | +169.45% | +31.62% | +1,065.58% | 11.7B | |
| +5.98% | -0.31% | -0.31% | +7.11% | -15.31% | -25.76% | +160.05% | +118.99% | - | 10.61B | |
| +29.91% | +7.24% | +16.57% | +40.24% | +258.89% | +85.28% | +22.52% | -92.60% | - | 10.32B | |
| +0.09% | -1.55% | +0.07% | +3.93% | +16.75% | +50.05% | +116.85% | +124.12% | +731.67% | 10.26B | |
| -0.24% | -0.86% | +3.05% | +20.74% | +29.69% | +93.03% | +16.19% | +130.86% | - | 8.85B | |
| +1.26% | -3.02% | +6.21% | +12.76% | +306.06% | +193.43% | +375.74% | -13.92% | - | 8.38B | |
| +3.05% | -3.43% | -5.82% | +5.34% | +5.56% | -31.16% | +100.00% | -25.71% | - | 8B | |
| +0.24% | -0.52% | -12.84% | +8.06% | +175.70% | +508.63% | +547.46% | -48.31% | -55.45% | 7.99B | |
| Average | +2.64% | -2.81% | +3.13% | +17.43% | +56.27% | +68.93% | +206.80% | +159.90% | +1,461.82% | 18.64B | |
| Weighted average by Cap. | +1.49% | -2.71% | +4.53% | +27.11% | +47.90% | +51.63% | +175.04% | +169.81% | +2,410.37% |
- Stock Market
- Stocks
- SPRO Stock
- Sector Spero Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
